Multi-omics of 34 colorectal cancer cell lines - a resource for biomedical studies (scientific article)

Dual-targeted therapy with trastuzumab and lapatinib in treatment-refractory, KRAS codon 12/13 wild-type, HER2-positive metastatic colorectal cancer (HERACLES): a proof-of-concept, multicentre, open-label, phase 2 trial

Q27853380

The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data

Q27860742

Proteogenomic characterization of human colon and rectal cancer

Q28244320

Gene expression classification of colon cancer into molecular subtypes: characterization, validation, and prognostic value

Q28488319

ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data

Q29547161

Signatures of mutational processes in human cancer

Q29547191

A framework for variation discovery and genotyping using next-generation DNA sequencing data

Q29547262

The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity

Q29547693

CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer

Q29614277

Integrated detection and population-genetic analysis of SNPs and copy number variation

Q29614584

PennCNV: an integrated hidden Markov model designed for high-resolution copy number variation detection in whole-genome SNP genotyping data

Q29614933

Proteomics. Tissue-based map of the human proteome

Q29617248

limma powers differential expression analyses for RNA-sequencing and microarray studies

Q29617988

Copynumber: Efficient algorithms for single- and multi-track copy number segmentation

Q30536665

GSVA: gene set variation analysis for microarray and RNA-seq data.

Q30586230

voom: Precision weights unlock linear model analysis tools for RNA-seq read counts

Q33741687

ADAM10 mediates trastuzumab resistance and is correlated with survival in HER2 positive breast cancer

Q34334333

The Molecular Signatures Database (MSigDB) hallmark gene set collection

Q34509167

Gene amplification in cancer

Q34540289

The chromosomal instability pathway in colon cancer

Q34570062

NCCN Clinical Practice Guidelines in Oncology: colon cancer

Q35002984

GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers

Q35557782

American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer

Q35806164

Intra-patient Inter-metastatic Genetic Heterogeneity in Colorectal Cancer as a Key Determinant of Survival after Curative Liver Resection.

Q36089548

The consensus molecular subtypes of colorectal cancer

Q36258187

Camera: a competitive gene set test accounting for inter-gene correlation

Q36280584

The exomes of the NCI-60 panel: a genomic resource for cancer biology and systems pharmacology

Q36971433

A colorectal cancer classification system that associates cellular phenotype and responses to therapy

Q37175913

Epigenetic and genetic features of 24 colon cancer cell lines

Q37275764

A multidimensional network approach reveals microRNAs as determinants of the mesenchymal colorectal cancer subtype.

Q37424650

Nucleotide selectivity defect and mutator phenotype conferred by a colon cancer-associated DNA polymerase δ mutation in human cells

Q38709274

The molecular landscape of colorectal cancer cell lines unveils clinically actionable kinase targets

Q38880745

Stromal contribution to the colorectal cancer transcriptome.

Q38906913

Colorectal cancer cell lines are representative models of the main molecular subtypes of primary cancer

Q39001975

Poor-prognosis colon cancer is defined by a molecularly distinct subtype and develops from serrated precursor lesions

Q39166874

Distribution of miRNA expression across human tissues

Q39964196

Genome signatures of colon carcinoma cell lines

Q40486412

Deregulated cyclin E induces chromosome instability

Q41692394

Cell lines from human colon carcinoma with unusual cell products, double minutes, and homogeneously staining regions

Q42801491

p53 and p21 form an inducible barrier that protects cells against cyclin E-cdk2 deregulation

Q44206924

Stromal gene expression defines poor-prognosis subtypes in colorectal cancer

Q48222476

Primary colon cancer: ESMO Clinical Practice Guidelines for diagnosis, adjuvant treatment and follow-up

Q57758169

P4510

describes a project that uses

Caco-2

HCT 116

HT-29

SW480

SW620

limma

GSVA

COLO 678

DLD-1

FRI

HCC2998

HCT 15

Isreco-1

Isreco-3

KM12

LoVo

LS1034

LS174T

CL-11

CL-34

CL-40

Co-115

COLO 205

COLO 320

NCI-H508

RKO

SW1116

SW1463

SW403

SW48

SW837

SW948

TC71

VACO 9P

WiDr

issue

main subject

colorectal cancer

cell line

colorectal carcinoma

page(s)

116

P577

publication date

2017-07-06

P1433

published in

Molecular Cancer

Q15724585

P1476

title

Multi-omics of 34 colorectal cancer cell lines - a resource for biomedical studies

P478

volume

Reverse relations

cites work (P2860)

Q56958430	A Systems-Level Analysis Reveals Circadian Regulation of Splicing in Colorectal Cancer
Q50281885	A robust internal control for high-precision DNA methylation analyses by droplet digital PCR.
Q52319633	AKT as a key target for growth promoting functions of neutral ceramidase in colon cancer cells.
Q92636061	An Fc-Optimized CD133 Antibody for Induction of Natural Killer Cell Reactivity against Colorectal Cancer
Q90231820	Analytical Evaluation of an NGS Testing Method for Routine Molecular Diagnostics on Melanoma Formalin-Fixed, Paraffin-Embedded Tumor-Derived DNA
Q47104672	CMScaller: an R package for consensus molecular subtyping of colorectal cancer pre-clinical models
Q92164128	Characterization of cancer omics and drug perturbations in panels of lung cancer cells
Q90153969	Colorectal cancer (CRC) as a multifactorial disease and its causal correlations with multiple signaling pathways
Q92431789	Colorectal cancer cells respond differentially to autophagy inhibition in vivo
Q90291632	Development of a Colorectal Cancer 3D Micro-tumor Construct Platform From Cell Lines and Patient Tumor Biospecimens for Standard-of-Care and Experimental Drug Screening
Q64949252	Effects of Copper Chelation on BRAFV600E Positive Colon Carcinoma Cells.
Q91618178	Evaluation of colorectal cancer subtypes and cell lines using deep learning
Q97539272	Exploring and modelling colon cancer inter-tumour heterogeneity: opportunities and challenges
Q92172753	Focused screening reveals functional effects of microRNAs differentially expressed in colorectal cancer
Q91904078	Gene expression profiles of CMS2-epithelial/canonical colorectal cancers are largely driven by DNA copy number gains
Q90217131	Identification of Eph receptor signaling as a regulator of autophagy and a therapeutic target in colorectal carcinoma
Q50188813	Integration of metabolomics and transcriptomics in nanotoxicity studies.
Q93081119	Intercellular Transfer of Oncogenic KRAS via Tunneling Nanotubes Introduces Intracellular Mutational Heterogeneity in Colon Cancer Cells
Q93185869	Long noncoding RNA MIR31HG is a bona fide prognostic marker with colorectal cancer cell-intrinsic properties
Q93173473	Long non‑coding RNA LINC00858 promotes TP53‑wild‑type colorectal cancer progression by regulating the microRNA‑25‑3p/SMAD7 axis
Q90589718	Loss of the nuclear Wnt pathway effector TCF7L2 promotes migration and invasion of human colorectal cancer cells
Q92187262	MiR-566 mediates cell migration and invasion in colon cancer cells by direct targeting of PSKH1
Q90910938	Mithramycin A Inhibits Colorectal Cancer Growth by Targeting Cancer Stem Cells
Q91307598	Molecular signature of interleukin-22 in colon carcinoma cells and organoid models
Q88727587	Molecular subtyping of colorectal cancer: Recent progress, new challenges and emerging opportunities
Q90381630	N6-Isopentenyladenosine Inhibits Colorectal Cancer and Improves Sensitivity to 5-Fluorouracil-Targeting FBXW7 Tumor Suppressor
Q64075446	Paracrine Induction of Epithelial-Mesenchymal Transition Between Colorectal Cancer Cells and its Suppression by a p53/miR-192/215/NID1 Axis
Q61818196	Pathway Analysis of Fucoidan Activity Using a Yeast Gene Deletion Library Screen
Q90689395	Perturbation of phosphoglycerate kinase 1 (PGK1) only marginally affects glycolysis in cancer cells
Q89529095	Prognostic and Predictive Molecular Biomarkers for Colorectal Cancer: Updates and Challenges
Q58776529	Prognostic, predictive, and pharmacogenomic assessments of CDX2 refine stratification of colorectal cancer
Q90189987	Similarities in the General Chemical Composition of Colon Cancer Cells and Their Microvesicles Investigated by Spectroscopic Methods-Potential Clinical Relevance
Q93173402	Sulforaphane suppresses carcinogenesis of colorectal cancer through the ERK/Nrf2‑UDP glucuronosyltransferase 1A metabolic axis activation
Q92022375	Synergy with TGFβ ligands switches WNT pathway dynamics from transient to sustained during human pluripotent cell differentiation
Q96762424	Syntenin-1 promotes colorectal cancer stem cell expansion and chemoresistance by regulating prostaglandin E2 receptor
Q92814017	Synthesis, CYP24A1-Dependent Metabolism and Antiproliferative Potential against Colorectal Cancer Cells of 1,25-Dihydroxyvitamin D2 Derivatives Modified at the Side Chain and the A-Ring
Q90354931	The microRNA-200 family acts as an oncogene in colorectal cancer by inhibiting the tumor suppressor RASSF2
Q97652843	Unique genomic and neoepitope landscapes across tumors: a study across time, tissues, and space within a single lynch syndrome patient
Q91198930	Visualization of epithelial-mesenchymal transition in an inflammatory microenvironment-colorectal cancer network
Q60312913	miR675 Accelerates Malignant Transformation of Mesenchymal Stem Cells by Blocking DNA Mismatch Repair